Convalescent plasma for SARS-CoV-2 infection: win or learn
Date
2022-02Permanent link
https://hdl.handle.net/11351/7732DOI
10.1183/13993003.02076-2021
ISSN
1399-3003
WOS
000798166900019
PMID
34531275
Abstract
Current evidence does not support the use of convalescent plasma in the standard therapy for COVID-19
Keywords
COVID-19; Convalescent plasmaBibliographic citation
Contreras-Barbeta E, Millan A, Rello J. Convalescent plasma for SARS-CoV-2 infection: win or learn. Eur Respir J. 2022 Feb;59(2):2102076.
Audience
Professionals
This item appears in following collections
- Col·lecció especial COVID-19 [945]
- VHIR - Articles científics [1751]
The following license files are associated with this item:





